EileenAmyRyanMD(She/Her)

Pathology • Rochester, NY

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Ryan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ryan's full profile

Already have an account?

Office
601 Elmwood Ave
University Of Rochester Medical Center; Box 608
Rochester, NY 14642
Phone+1 585-275-3184

Education & Training

University of RochesterResidency, Pathology-Anatomic and Clinical, 1976 - 1981
University of Rochester Medical CenterInternship, Transitional Year, 1975 - 1976
Johns Hopkins University School of MedicineClass of 1975

Certifications & Licensure

NY State Medical License 1980 - 2024
American Board of Pathology Anatomic Pathology & Clinical Pathology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Publications & Presentations

PubMed

589 citations
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute My...
Jeffrey E. Lancet, Geoffrey L. Uy, Jorge E. Cortes, Laura F. Newell, Tara L. Lin
Journal of Clinical Oncology. 2018-07-19
183 citations
Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells.
Daniel H. Ryan, Bonnie Nuccie, Camille N. Abboud, J M Winslow
The Journal of Clinical Investigation. 1991-09-01
34 citations
Maturation-dependent adhesion of human B cell precursors to the bone marrow microenvironment.
Daniel H. Ryan, Bonnie Nuccie, Camille N. Abboud, Jane L. Liesveld
Journal of Immunology. 1990-07-15

Abstracts/Posters

Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 ...
Daniel H. Ryan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (AML) with Prior Hypomethylatin...
Daniel H. Ryan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Anal...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

September 5, 2020September 5th, 2020

Grant Support

B Lineage Development Of Human Hematopoietic ProgenitorsNational Cancer Institute1998–2000
Biology Of Calla + Cells In Lymphoblastic LeukemiaNational Cancer Institute1985–1987

Professional Memberships

Association of Pathology Chairs
Fellow